De Renzo, A <br/><br/>
Etoposide and idarubicin in a modified CHOP-like regimen (VICED) for aggressive non-Hodgkin's lymphomas.  [electronic resource] 

 -  Leukemia & lymphoma  Jun 1998 
 - 153-62 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1042-8194 
<br/><br/><label>Standard No.: </label>10.3109/10428199809050938  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cyclophosphamide--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>Humans<br/>Idarubicin--administration & dosage<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Prognosis<br/>Survival Rate<br/>Treatment Outcome<br/>Vincristine--administration & dosage